Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

Transneft to reduce crude oil exports by 6.5% in 2023

1/10/24 TRNFP

Mosgorlombard shareholders approved the conversion of preferred shares

1/10/24 MGKL

Severstal acquires a steel structures production facility

1/10/24 CHMF

Fix Price received authorization to pay dividends to the holding company

1/10/24 FIXP

Softline acquired a developer of payment terminals

1/10/24 SOFL

Gazprom Neft will study the underlying horizons of the Verkhnesalymsky block

1/10/24 SIBN

Sistema became the owner of La Datcha guest complex

1/10/24 AFKS

Fix Price plans to open at least 750 stores

1/9/24 FIXP

Fesco air delivery service transported 4 times more groupage cargoes

1/9/24 FESH

PIK lost its leadership in terms of current construction volumes

1/9/24 PIKK